Artwork

Content provided by Clinical Care Options, LLC and Clinical Care Options. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Clinical Care Options, LLC and Clinical Care Options or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Key Decisions in HIV Care: Treatment Considerations for Transgender PWH

28:12
 
Share
 

Manage episode 329726502 series 2884624
Content provided by Clinical Care Options, LLC and Clinical Care Options. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Clinical Care Options, LLC and Clinical Care Options or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode, Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS, explores key considerations for transgender people with HIV (PWH).

Listen as she gives perspectives on:

  • Department of Health and Human Services (DHHS) guideline recommendations for transgender PWH
  • Providing HIV care within a gender-affirmative care model, including discussion of strategies, barriers, and facilitators
  • Gender-affirmative hormone therapy options
  • Drug–drug interaction potential between gender-affirmative hormone therapy and antiretroviral therapy
  • Recommended laboratory monitoring while receiving gender-affirming hormone therapy
  • The cascade of care for transgender PWH and barriers to engagement and retention in care

Presenter:

Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS
Assistant Professor of Pediatrics
Division of Pediatric Infectious Diseases
Pediatric and Adolescent HIV
Children’s Hospital at Montefiore
Pediatric Hospital of Albert Einstein
College of Medicine
Bronx, New York

Follow along with the slides at:
https://bit.ly/3wOdKVo

Link to full program:
https://bit.ly/3fOl0XX

  continue reading

375 episodes

Artwork
iconShare
 
Manage episode 329726502 series 2884624
Content provided by Clinical Care Options, LLC and Clinical Care Options. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Clinical Care Options, LLC and Clinical Care Options or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode, Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS, explores key considerations for transgender people with HIV (PWH).

Listen as she gives perspectives on:

  • Department of Health and Human Services (DHHS) guideline recommendations for transgender PWH
  • Providing HIV care within a gender-affirmative care model, including discussion of strategies, barriers, and facilitators
  • Gender-affirmative hormone therapy options
  • Drug–drug interaction potential between gender-affirmative hormone therapy and antiretroviral therapy
  • Recommended laboratory monitoring while receiving gender-affirming hormone therapy
  • The cascade of care for transgender PWH and barriers to engagement and retention in care

Presenter:

Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS
Assistant Professor of Pediatrics
Division of Pediatric Infectious Diseases
Pediatric and Adolescent HIV
Children’s Hospital at Montefiore
Pediatric Hospital of Albert Einstein
College of Medicine
Bronx, New York

Follow along with the slides at:
https://bit.ly/3wOdKVo

Link to full program:
https://bit.ly/3fOl0XX

  continue reading

375 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide